Remed Co (XKRX:302550) Gross Margin %

: 47.72% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Remed Co's Gross Profit for the three months ended in Dec. 2023 was ₩2,059 Mil. Remed Co's Revenue for the three months ended in Dec. 2023 was ₩4,315 Mil. Therefore, Remed Co's Gross Margin % for the quarter that ended in Dec. 2023 was 47.72%.

Warning Sign:

Remed Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.2%.

The historical rank and industry rank for Remed Co's Gross Margin % or its related term are showing as below:

XKRX:302550' s Gross Margin % Range Over the Past 10 Years
Min: 48.73 Med: 51.95 Max: 57.55
Current: 48.73

During the past 7 years, the highest Gross Margin % of Remed Co was 57.55%. The lowest was 48.73%. And the median was 51.95%.

XKRX:302550's Gross Margin % is ranked worse than
58.29% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs XKRX:302550: 48.73

Remed Co had a gross margin of 47.72% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Remed Co was -1.20% per year.

Remed Co Gross Margin % Historical Data

The historical data trend for Remed Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

57.55

51.95

51.55

52.39

48.73

Remed Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Take a 7-Day Free Trial															47.20	54.51	44.43	47.74	47.72

Competitive Comparison

For the Medical Devices subindustry, Remed Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Remed Co Gross Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Remed Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Remed Co's Gross Margin % falls into.

Remed Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Remed Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	9033	/	18536.135
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(18536.135 - 9503.095)	/	18536.135
	=	48.73 %

Remed Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	2059.2	/	4315.204
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(4315.204 - 2256.024)	/	4315.204
	=	47.72 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Remed Co (XKRX:302550) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Remed Co had a gross margin of 47.72% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Remed Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Remed Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Remed Co (XKRX:302550) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025

Website

http://www.remed.kr

Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co (XKRX:302550) Headlines

No Headlines